Table 2.
Summary of patients’ diagnosis regarding the whole cohort included in the study.
| Diagnosis | Patients Number (%) |
|---|---|
| Diabetic nephropathy | 3625 (40.7) |
| CKD without specifying the underlying cause | 2675 (30.1) |
| IgA nephropathy | 362 (4.1) |
| Renal transplant recipients | 313 (3.5) |
| Lupus nephritis | 106 (1.2) |
| Systemic lupus erythematosus | 75 (0.8) |
| Generically reported as biopsy-proven renal fibrosis | 58 (0.6) |
| Acute kidney injury | 50 (0.5) |
| ANCA-associated vasculitis | 47 (0.5) |
| Unilateral hydronephrosis | 45 children (0.5) |
| Membranous nephropathy | 45 (0.5) |
| HIV-positive CKD | 25 (0.3) |
| Minimal change disease | 23 (0.25) |
| Obstructive uropathy | 23 (0.25) |
| Hypertensive nephrosclerosis | 21 (0.2) |
| Focal segmental glomerulosclerosis | 17 (0.2) |
| Hypo/dysplastic kidney | 15 (0.2) |
| Reflux nephropathy | 14 (0.15) |
| ANCA-associated nephritis | 12 (0.1) |
| Minor histopathologic abnormality | 11 (0.1) |
| Renal amyloidosis | 6 (0.05) |
| Cast nephropathy | 5 (0.05) |
| Polycystic kidney disease | 4 (0.05) |
| Thin basement membrane disease | 3 (0.03) |
| Thrombotic microangiopathy | 2 (0.02) |
| Membranous proliferative glomerulonephritis | 2 (0.02) |
| Post-infectious glomerulonephritis | 1 (0.01) |
| Crescentic glomerulonephritis | 1 (0.01) |
| Uric acid nephropathy | 1 (0.01) |
| General population (prospectively followed) | 1302 (14.6) |